Wikidata

(Q40781853)

English

Intralesional infusion of lymphokine-activated killer (LAK) cells and recombinant interleukin-2 (rIL-2) for the treatment of patients with malignant brain tumor

scientific article

In more languages

Statements

title
Intralesional infusion of lymphokine-activated killer (LAK) cells and recombinant interleukin-2 (rIL-2) for the treatment of patients with malignant brain tumor (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
2851116
retrieved
23 September 2017
main subject
interleukins
0 references
author name string
Merchant RE
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
2851116
retrieved
23 September 2017
Merchant LH
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
2851116
retrieved
23 September 2017
Cook SH
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
2851116
retrieved
23 September 2017
McVicar DW
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
2851116
retrieved
23 September 2017
Young HF
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
2851116
retrieved
23 September 2017
publication date
1 December 1988
1 reference
stated in
Europe PubMed Central
PubMed ID
2851116
retrieved
23 September 2017
page(s)
725-732
1 reference
stated in
Europe PubMed Central
PubMed ID
2851116
retrieved
23 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40781853&oldid=1907322476"